AMAG Pharmaceuticals to Present at the Deutsche Bank Health Care Conference
April 26 2017 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
management will participate in a fireside chat at the 42nd Annual
Deutsche Bank Health Care Conference on Wednesday, May 3, 2017 at
2:50 p.m. ET.
A live audio webcast will be accessible through the Investors
section of the company’s website at www.amagpharma.com, and
will be archived for 30 days.
About AMAGAMAG is a
biopharmaceutical company focused on developing and delivering
important therapeutics, conducting clinical research in areas of
unmet need and creating education and support programs for the
patients and families we serve. Our currently marketed products
support the health of patients in the areas of maternal and women’s
health, anemia management and cancer supportive care. Through CBR®,
we also help families to preserve newborn stem cells, which are
used today in transplant medicine for certain cancers and blood,
immune and metabolic disorders, and have the potential to play a
valuable role in the ongoing development of regenerative medicine.
For additional company information, please
visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc. and CBR® is a registered trademark
of CBR Systems, Inc.
AMAG Pharmaceuticals Contact:
Christi Waarich
Associate Director, Investor Relations
617-498-7638
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Sep 2023 to Sep 2024